Latest Feature

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

Podcast: Medtech legends and leaders on the state of medical device innovation

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

CardioMEMS took 11 years to pay off, but for Boston Millennia it was worth it

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

Podcast: Haemonetics CEO Brian Concannon at MassDevice.com's DeviceTalks

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for August 28, 2014

August 28, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

FDA warns Vention Medical on Costa Rica plant

August 28, 2014 by Brad Perriello

The FDA flags Vention Medical for violations found during an inspection last spring of a plant in Costa Rica.

FDA warns Vention Medical on Costa Rica plant

The FDA last month slapped Vention Medical with a warning letter over conditions at a plant in Costa Rica, flagging problems with the medical device company's procedures there.

The July 1 letter was prompted by an FDA inspection in March of a plant in Barreal de Heredia, Costa Rica, the FDA said.

Zimmer asks judge to sanction plaintiffs' lawyers in knee implant lawsuits

August 28, 2014 by Brad Perriello

Zimmer Holdings wants a federal judge to impose sanctions against the lawyers in 3 cases from the multi-district litigation filed over its knee implants, claiming that the cases should never have been brought in the 1st place.

Zimmer seeks sanctions against plaintiffs' lawyers in knee implant lawsuits

CorMatrix lands FDA win, touts 1st human implant of CanGaroo surgical pouch

August 28, 2014 by Arezu Sarvestani

CorMatrix secure FDA clearance for its CanGaroo ECM envelope for use with implantable cardiac devices and touts 1st human use in a patient at Ohio's Cleveland Clinic.

CorMatrix lands FDA win, touts 1st human implant of CanGaroo surgical evelope

Georgia medical device maker CorMatrix touted an FDA win this month, landing regulatory clearance for its CanGaroo surgical envelope for securing implantable cardiac devices.

Press Release: CorMatrix reports FDA clearance of CorMatrix CanGaroo ECM Envelope

August 28, 2014 by MassDevice

Press Release: CorMatrix reports FDA clearance of CorMatrix CanGaroo ECM Envelope

Roswell, Georgia – CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with cardiac implantable electronic devices (CIED's) including pacemakers and implantable cardioverter defibrillators (ICD's).

Masimo takes new infant monitors to Europe, Japan

August 28, 2014 by Arezu Sarvestani

Masimo wins clearance in Japan and approval in Europe for its rainbow DCI-mini non-invasive hemoglobin monitor for infants and small kids.

Masimo takes new pediatric monitors to Europe, Japan

California-based medical device maker Masimo (NSDQ:MASI) is planning a limited market launch of its 1st-of-its kind hemoglobin monitor for infants and small children after winning approval from regulators in Japan and Europe.

Press Release: Masimo announces CE Mark and limited market release of rainbow DCI-mini

August 28, 2014 by MassDevice

First noninvasive total haemoglobin (SpHb) spot-check sensor for infants and small children.

Press Release: Masimo announces CE Mark and limited market release of rainbow DCI-mini
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp